ANIXA BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
ANIXA BIOSCIENCES, INC. (ANIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-01-12
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-07-31 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-04-30 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2015-01-31 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2014-07-31 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-10-31 | 0.00% 10-K · filed 2026-01-12 | |||
| 2024-10-31 | 0.00% 10-K · filed 2026-01-12 | |||
| 2023-10-31 | 0.00% 10-K · filed 2025-01-10 | |||
| 2022-10-31 | 0.00% 10-K · filed 2024-01-16 | |||
| 2021-10-31 | 0.00% 10-K · filed 2023-01-04 | |||
| 2020-10-31 | 0.00% 10-K · filed 2022-01-04 | |||
| 2019-10-31 | 0.00% 10-K · filed 2021-01-07 | |||
| 2018-10-31 | 0.00% 10-K · filed 2020-01-09 | |||
| 2017-10-31 | 0.00% 10-K · filed 2019-01-11 | |||
| 2016-10-31 | 0.00% 10-K · filed 2018-01-09 | |||
| 2015-10-31 | 0.00% 10-K · filed 2016-12-08 | |||
| 2015-07-31 | 0.00% 10-Q · filed 2015-08-18 | 0.00% 10-Q · filed 2015-08-18 | ||
| 2015-04-30 | 0.00% 10-Q · filed 2015-05-22 | 0.00% 10-Q · filed 2015-05-22 | ||
| 2015-01-31 | 0.00% 10-Q · filed 2015-03-09 | |||
| 2014-10-31 | 0.00% 10-K · filed 2015-12-23 | |||
| 2014-07-31 | 0.00% 10-Q · filed 2015-08-18 | 0.00% 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | 0.00% 10-Q · filed 2014-06-16 | 0.00% 10-Q · filed 2015-05-22 | ||
| 2014-01-31 | 0.00% 10-Q · filed 2015-03-09 | |||
| 2013-10-31 | 0.00% 10-K · filed 2015-01-29 | |||
| 2013-07-31 | 0.00% 10-Q · filed 2014-09-15 | |||
| 2013-04-30 | 0.00% 10-Q · filed 2014-06-16 | 0.00% 10-Q · filed 2014-06-16 | ||
| 2013-01-31 | 0.00% 10-Q · filed 2014-03-17 | |||
| 2012-10-31 | 0.00% 10-K/A · filed 2014-01-17 | |||
| 2012-07-31 | 0.00% 10-Q/A · filed 2013-09-20 | |||
| 2012-04-30 | 0.00% 10-Q/A · filed 2013-06-19 | 0.00% 10-Q/A · filed 2013-06-19 | ||
| 2012-01-31 | 0.00% 10-Q/A · filed 2013-03-25 | |||
| 2011-07-31 | 0.00% 10-Q · filed 2012-09-14 | 0.00% 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |